HMDB0000012 | Deoxyuridine | 951-78-0 | | C9H12N2O5 | 228.202 228.074621504 | Not Available |
HMDB0000034 | Adenine | 73-24-5 | | C5H5N5 | 135.1267 135.054495185 | Not Available |
HMDB0000050 | Adenosine | 58-61-7 | | C10H13N5O4 | 267.2413 267.096753929 | Not Available |
HMDB0000071 | Deoxyinosine | 890-38-0 | | C10H12N4O4 | 252.23 252.085854882 | Not Available |
HMDB0000085 | Deoxyguanosine | 961-07-9 | | C10H13N5O4 | 267.2413 267.096753929 | Not Available |
HMDB0000101 | Deoxyadenosine | 958-09-8 | | C10H13N5O3 | 251.2419 251.101839307 | Not Available |
HMDB0000132 | Guanine | 73-40-5 | | C5H5N5O | 151.1261 151.049409807 | - Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [PubMed:17139284 ]
- Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [PubMed:17016423 ]
|
HMDB0000133 | Guanosine | 118-00-3 | | C10H13N5O5 | 283.2407 283.091668551 | - Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [PubMed:17139284 ]
- Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [PubMed:17016423 ]
|
HMDB0000157 | Hypoxanthine | 68-94-0 | | C5H4N4O | 136.1115 136.03851077 | - Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [PubMed:17139284 ]
- Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [PubMed:17016423 ]
- Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [PubMed:10592235 ]
|
HMDB0000195 | Inosine | 58-63-9 | | C10H12N4O5 | 268.2261 268.080769514 | - Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [PubMed:17139284 ]
- Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [PubMed:17016423 ]
- Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [PubMed:10592235 ]
|
HMDB0000292 | Xanthine | 69-89-6 | | C5H4N4O2 | 152.1109 152.033425392 | Not Available |
HMDB0000299 | Xanthosine | 146-80-5 | | C10H12N4O6 | 284.2255 284.075684136 | Not Available |
HMDB0000300 | Uracil | 66-22-8 | | C4H4N2O2 | 112.0868 112.027277382 | Not Available |
HMDB0000855 | Nicotinamide riboside | 1341-23-7 | | C11H15N2O5 | 255.2472 255.0980966 | Not Available |
HMDB0001351 | Deoxyribose 1-phosphate | 17210-42-3 | | C5H11O7P | 214.1104 214.024239218 | Not Available |
HMDB0001366 | Purine | 120-73-0 | | C5H4N4 | 120.1121 120.043596148 | Not Available |
HMDB0001406 | Niacinamide | 98-92-0 | | C6H6N2O | 122.1246 122.048012824 | Not Available |
HMDB0001429 | Phosphate | 14265-44-2 | | H3O4P | 97.9952 97.976895096 | Not Available |
HMDB0001488 | Nicotinic acid | 59-67-6 | | C6H5NO2 | 123.1094 123.032028409 | Not Available |
HMDB0001489 | Ribose 1-phosphate | 14075-00-4 | | C5H11O8P | 230.1098 230.01915384 | Not Available |
HMDB0006809 | Nicotinic acid ribonucleoside | 4013-06-3 | | C11H14NO6 | 256.232 256.082112185 | Not Available |
HMDB0014387 | Cladribine | 4291-63-8 | | C10H12ClN5O3 | 285.687 285.062866982 | - Bzowska A, Kazimierczuk Z: 2-Chloro-2'-deoxyadenosine (cladribine) and its analogues are good substrates and potent selective inhibitors of Escherichia coli purine-nucleoside phosphorylase. Eur J Biochem. 1995 Nov 1;233(3):886-90. [PubMed:8521855 ]
- Dumontet C, Fabianowska-Majewska K, Mantincic D, Callet Bauchu E, Tigaud I, Gandhi V, Lepoivre M, Peters GJ, Rolland MO, Wyczechowska D, Fang X, Gazzo S, Voorn DA, Vanier-Viornery A, MacKey J: Common resistance mechanisms to deoxynucleoside analogues in variants of the human erythroleukaemic line K562. Br J Haematol. 1999 Jul;106(1):78-85. [PubMed:10444166 ]
- Dumontet C, Bauchu EC, Fabianowska K, Lepoivre M, Wyczechowska D, Bodin F, Rolland MO: Common resistance mechanisms to nucleoside analogues in variants of the human erythroleukemic line K562. Adv Exp Med Biol. 1999;457:571-7. [PubMed:10500836 ]
- Takimoto T, Kubota M, Tsuruta S, Kitoh T, Tanizawa A, Akiyama Y, Kiriyama Y, Mikawa H: Changes in sensitivity to anticancer drugs during TPA-induced cellular differentiation in a human T-lymphoblastoid cell line (MOLT-4). Leukemia. 1988 Jul;2(7):443-6. [PubMed:3260648 ]
- Carson DA, Wasson DB, Lakow E, Kamatani N: Possible metabolic basis for the different immunodeficient states associated with genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase. Proc Natl Acad Sci U S A. 1982 Jun;79(12):3848-52. [PubMed:6808516 ]
|
HMDB0015037 | Didanosine | 69655-05-6 | | C10H12N4O3 | 236.2273 236.09094027 | - Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [PubMed:17139284 ]
- Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [PubMed:17016423 ]
|
HMDB0029956 | Nebularine | 550-33-4 | | C10H12N4O4 | 252.2267 252.085854892 | Not Available |
HMDB0059597 | Hydrogen Ion | | | H | 1.0079 1.007825032 | Not Available |